Scaleable TMS footprint Salience operates 10+ clinics with 51-200 employees and a mission to expand TMS treatment access, presenting a growth opportunity through partner networks, franchise-style expansion, or white-labeling scalable TMS delivery models to reach more patients.

Clinical credibility With over 100,000 TMS treatments performed and a patient remission focus, Salience offers a strong case study profile for payers and referral partners seeking proven outcomes in mood disorder treatment, enabling stronger co-marketing and outcomes-based reimbursement discussions.

Insurance navigation Patient advocates assist with insurance and billing options, indicating readiness to collaborate on payer-facing programs, streamlined credentialing, and simplified claim processes to reduce friction for new partnerships.

Tech-enabled ops A tech stack spanning AWS, Salesforce, iCIMS, Shopify, WordPress and marketing tools suggests opportunities to offer integrated patient journey solutions, CRM-enhanced referral intake, and data-driven outcomes reporting for partners.

Growth profile Revenue range and headcount imply a mid-market player poised for scale; potential targets include regional health systems, group practices, and payers seeking to expand neuromodulation services, with Salience as a ready-to-scale provider partner.